81 related articles for article (PubMed ID: 24197277)
1. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
[TBL] [Abstract][Full Text] [Related]
2. Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer.
Cantón-Romero JC; Miranda-Díaz AG; Bañuelos-Ramírez JL; Carrillo-Ibarra S; Sifuentes-Franco S; Castellanos-González JA; Rodríguez-Carrizalez AD
Oxid Med Cell Longev; 2017; 2017():2873030. PubMed ID: 28848618
[TBL] [Abstract][Full Text] [Related]
3. Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.
Ose J; Schock H; Poole EM; Lehtinen M; Visvanathan K; Helzlsouer K; Buring JE; Lee IM; Tjønneland A; Boutron-Ruault MC; Trichopoulou A; Mattiello A; Onland-Moret NC; Weiderpass E; Sánchez MJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
Cancer Causes Control; 2017 May; 28(5):429-435. PubMed ID: 28205047
[TBL] [Abstract][Full Text] [Related]
4. Role of C-reactive protein in the bone marrow of Modic type 1 changes.
Dudli S; Heggli I; Laux CJ; Spirig JM; Wanivenhaus F; Betz M; Germann C; Farshad-Amacker NA; Herger N; Mengis T; Brunner F; Farshad M; Distler O
J Orthop Res; 2023 May; 41(5):1115-1122. PubMed ID: 36062874
[TBL] [Abstract][Full Text] [Related]
5. Serum Interleukin-6 Levels and Pulmonary Function in Ataxia-Telangiectasia.
McGrath-Morrow SA; Collaco JM; Detrick B; Lederman HM
J Pediatr; 2016 Apr; 171():256-61.e1. PubMed ID: 26851119
[TBL] [Abstract][Full Text] [Related]
6. The Association of Kidney Function and Inflammatory Biomarkers with Epithelial Ovarian Cancer Risk.
Hathaway CA; Townsend MK; Sklar EM; Thomas-Purcell KB; Terry KL; Trabert B; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1451-1457. PubMed ID: 37540498
[TBL] [Abstract][Full Text] [Related]
7. C‑reactive protein and related predictors in soft tissue sarcoma (Review).
Nakamura T; Asanuma K; Hagi T; Sudo A
Mol Clin Oncol; 2024 Jan; 20(1):6. PubMed ID: 38125741
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer.
Sanguinete MMM; Oliveira PH; Martins-Filho A; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2017 Oct; 46(7):677-688. PubMed ID: 28872976
[TBL] [Abstract][Full Text] [Related]
9. Cytokines in peritoneal fluid of ovarian neoplasms.
de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
[TBL] [Abstract][Full Text] [Related]
10. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer.
Rodrigues ISS; Martins-Filho A; Micheli DC; Lima CA; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2020 Jul; 49(5):510-521. PubMed ID: 31755326
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer.
Kumar A; Torres ML; Cliby WA; Kalli KR; Bogani G; Aletti G; Nitschmann CC; Multinu F; Weaver AL; Block MS; Mariani A
Anticancer Res; 2017 Jul; 37(7):3673-3677. PubMed ID: 28668859
[TBL] [Abstract][Full Text] [Related]
12. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
[TBL] [Abstract][Full Text] [Related]
13. Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells.
Islam SS; Al-Mohanna FH; Yousef IM; Al-Badawi IA; Aboussekhra A
Cell Death Dis; 2024 Apr; 15(4):247. PubMed ID: 38575576
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis.
Zhang W; Zhang Z; Qian L
World J Surg Oncol; 2024 Jan; 22(1):8. PubMed ID: 38172843
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin B1 Receptor Affects Tumor-Associated Macrophage Activity and Glioblastoma Progression.
Shen CK; Huang BR; Charoensaensuk V; Yang LY; Tsai CF; Liu YS; Lu DY; Yeh WL; Lin C
Antioxidants (Basel); 2023 Jul; 12(8):. PubMed ID: 37627528
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer.
Bizoń M; Awiżeń-Panufnik Z; Sawicki W
J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373969
[TBL] [Abstract][Full Text] [Related]
17. Is the serum level of survivin, an antiapoptotic protein, a potential predictive and prognostic biomarker in metastatic pancreatic cancer?
Demirci NS; Çavdar E; Erdem GU; Hatipoglu E; Celik E; Sezer S; Yolcu A; Dogan M; Seber ES
Medicine (Baltimore); 2023 Jun; 102(25):e34014. PubMed ID: 37352081
[TBL] [Abstract][Full Text] [Related]
18. The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma.
Pan Q; Wei M; Lu M; Xu Y; Xie X; Li X
Cancer Manag Res; 2023; 15():233-243. PubMed ID: 36873254
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial Ovarian Cancer via the IL-6/STAT3/HIF-1
Zhang T; Yang J; Sun Y; Song J; Gao D; Huang S; Pang A; Zhang J; Wang J; Wang Y; Li Y
Anal Cell Pathol (Amst); 2023; 2023():8334881. PubMed ID: 36814597
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
